{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T14:22:13Z","timestamp":1778854933695,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T00:00:00Z","timestamp":1261094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2010,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Optimal diagnostic criteria for the 4\u2010mg intravenous dexamethasone suppression test (IVDST) in patients with Cushing\u2019s syndrome (CS), compared with normal subjects, have not been established. We evaluated the performance of the 4\u2010mg IVDST for differentiating CS from normal subjects and to define the responses in CS of various aetiologies.<\/jats:p><jats:p><jats:bold>Design, subjects, measurements\u2002<\/jats:bold> Thirty\u2010two control subjects [normal and overweight\/obese participants with or without type 2 diabetes) were prospectively studied, and data from 66 patients with Cushing\u2019s disease (CD), three with ectopic ACTH syndrome (EAS), 14 with adrenal Cushing\u2019s (AC)] and 15 with low probability of CS (LPC) from three tertiary hospitals were retrospectively evaluated. Dexamethasone was infused at 1\u2003mg\/h for 4\u2003h. Plasma cortisol and ACTH were measured at \u221260\u2003min (baseline), \u22125\u2003min, +3\u2003h, +4\u2003h, +5\u2003h and at +23 and +23\u00b75\u2003h on Day 2.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Control subjects (including those with type 2 diabetes) exhibited a marked suppression of cortisol which was maintained until Day 2. Two of 15 patients with LPC had Day 2 cortisol results that overlapped with CS. Patients with CD demonstrated partial suppression, with rebound hypercortisolism on Day 2. Patients with AC and EAS did not suppress cortisol levels. Day 2 cortisol level of &gt;130\u2003nmol\/l (or &gt;20% of the baseline) diagnosed CS with 100% sensitivity and 96% specificity.<\/jats:p><jats:p><jats:bold>Conclusion\u2002<\/jats:bold> While the IVDST allowed complete discrimination between control subjects and CS, 13% of LPC overlapped with CS. Given the small number of EAS, no conclusion can be drawn regarding the utility of this test in the differential diagnosis of CS.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2009.03756.x","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T14:45:14Z","timestamp":1261147514000},"page":"78-84","source":"Crossref","is-referenced-by-count":12,"title":["The 4\u2010mg intravenous dexamethasone suppression test in the diagnosis of Cushing\u2019s syndrome"],"prefix":"10.1111","volume":"73","author":[{"given":"Caroline","family":"Jung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank P.","family":"Alford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan J.","family":"Topliss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Gome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim R.","family":"Stockigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Warrick J.","family":"Inder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,6,14]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030871"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04172-6"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb04417.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.20.3045"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.19.5.647"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1515\/JPEM.1995.8.1.27","article-title":"Single intravenous bolus of dexamethasone for the differential diagnosis of Cushing\u2019s syndrome","volume":"8","author":"Shilo S.","year":"1995","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"e_1_2_6_9_2","first-page":"753","article-title":"A weight\u2010related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing\u2019s syndrome","volume":"120","author":"Atkinson A.B.","year":"1989","journal-title":"Acta Endocrinologica (Copenhagen)"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0330515"},{"key":"e_1_2_6_11_2","first-page":"54","article-title":"Comparison of oral and intravenous dexamethasone suppression tests in the differential diagnosis of Cushing\u2019s syndrome","volume":"72","author":"Croughs R.J.","year":"1973","journal-title":"Acta Endocrinologica (Copenhagen)"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-61-1-116"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.52.103"},{"key":"e_1_2_6_14_2","first-page":"1380","article-title":"Test of pituitary adrenal restraining with IV dexamethasone in the diagnosis of Cushing\u2019s syndrome","volume":"56","author":"Linquette M.","year":"1980","journal-title":"La Semaine des Hopitaux de Paris"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-112-10-738"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00759.x"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03349953"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70233-4"},{"key":"e_1_2_6_19_2","first-page":"52","article-title":"Investigation strategy in the diagnosis of Cushing\u2019s syndrome","volume":"27","author":"Beauregard C.","year":"2003","journal-title":"Canadian Journal of Diabetes"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.737558.x"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030254"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0070"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-58-1-134"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90116-7"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030207"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00555.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2004.01.009"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1211003"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2009.03756.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2009.03756.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T15:47:35Z","timestamp":1698767255000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2009.03756.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,14]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["10.1111\/j.1365-2265.2009.03756.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2009.03756.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,14]]}}}